• Price (EUR)89.68
  • Today's Change-0.75 / -0.83%
  • Shares traded65.00
  • 1 Year change19.91%
  • Beta0.8945
Data delayed at least 15 minutes, as of Oct 30 2020 09:27 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Key statistics

As of last trade Abbott Laboratories (ABLX:GER) traded at 89.68, -8.29% below its 52-week high of 97.79, set on Aug 28, 2020.
52-week range
58.76Mar 23 202097.79Aug 28 2020
Markit short selling activity
Previous close90.43
Average volume1.41k
Shares outstanding1.77bn
Free float1.76bn
P/E (TTM)55.86
Market cap185.91bn USD
EPS (TTM)1.88
Annual div (ADY)1.23
Annual div yield (ADY)1.36%
Div ex-dateOct 14 2020
Div pay-dateNov 16 2020
Data delayed at least 15 minutes, as of Oct 30 2020 09:27 BST.
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.